Cargando…

Prognostic values of novel biomarkers in patients with AL amyloidosis

As cardiac involvement is the most important prognostic marker in light-chain amyloidosis (AL), revised Mayo staging for AL incorporated N-terminal pro-brain natriuretic peptide (NTproBNP) and troponin T (TnT). However, prognostic value of novel biomarkers, such as soluble suppression of tumorigenic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Darae, Lee, Ga Yeon, Choi, Jin-Oh, Kim, Kihyun, Kim, Seok Jin, Ju, Eun-Seon, Jeon, Eun-Seok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704139/ https://www.ncbi.nlm.nih.gov/pubmed/31434944 http://dx.doi.org/10.1038/s41598-019-48513-6

Ejemplares similares

Untangling Amyloidosis: Recent Advances in Cardiac Amyloidosis
por: Kim, Darae, et al.
Publicado: (2020)

Associations of Electrocardiographic Parameters with Left Ventricular Longitudinal Strain and Prognosis in Cardiac Light Chain Amyloidosis
por: Kim, Darae, et al.
Publicado: (2019)

Clinical and prognostic implications of capillary density in patients with cardiac light chain amyloidosis
por: Kim, Darae, et al.
Publicado: (2021)

Prognostic Implication of Longitudinal Changes of Left Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amyloidosis
por: Bak, Minjung, et al.
Publicado: (2022)

Corrigendum: Prognostic implication of longitudinal changes of left ventricular global strain after chemotherapy in cardiac light chain amyloidosis
por: Bak, Minjung, et al.
Publicado: (2022)

A Novel Transthyretin Gene Mutation in Hereditary Transthyretin Amyloidosis: A Case Series of Met13dup Patients
por: Jeon, Kina, et al.
Publicado: (2023)

Outcomes of bortezomib combination chemotherapies in autologous stem cell transplantation-ineligible patients with AL amyloidosis
por: Hur, Joon Young, et al.
Publicado: (2021)

(99m)Tc-DPD scintigraphy and SPECT/CT in patients with AL and ATTR type amyloidosis: Potential clinical implications
por: Lee, Joohee, et al.
Publicado: (2020)

Direct comparison of diagnostic and clinical values between Tc-99 m DPD and Tc-99 m PYP scintigraphy in patients with cardiac amyloidosis
por: Park, Yong-Jin, et al.
Publicado: (2023)

Incidence, Cause of Death, and Survival of Amyloidosis in Korea: A Retrospective Population-Based Study
por: Jang, Shin Yi, et al.
Publicado: (2021)

Cardiac Amyloidosis Determines the Prognosis of Systemic Amyloidosis; Roles and Responsibilities of Cardiologist
por: Lee, Ga Yeon, et al.
Publicado: (2013)

Clinical features and outcomes of systemic amyloidosis with gastrointestinal involvement: a single-center experience
por: Lim, A Young, et al.
Publicado: (2015)

Looking into a Whole Picture: Ventricular Vascular Coupling-Refining Cardiovascular Risk Stratification in Patients with Obstructive Sleep Apnea
por: Kim, Darae, et al.
Publicado: (2020)

Characteristics of South Korean Patients with Hereditary Transthyretin Amyloidosis
por: Choi, Kyomin, et al.
Publicado: (2018)

Role of Soluble ST2 as a Marker for Rejection after Heart Transplant
por: Lee, Ga Yeon, et al.
Publicado: (2016)

Clinical outcome in patients with end-stage heart failure who underwent continuous-flow left ventricular assist devices in a single center
por: Park, Yoonjee, et al.
Publicado: (2022)

Prognostic value of myocardial strain and late gadolinium enhancement on cardiovascular magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy with moderate to severely reduced ejection fraction
por: Pi, Seung-Hoon, et al.
Publicado: (2018)

A Case of Femoral Compressive Neuropathy in AL Amyloidosis
por: Kang, Eun Ha, et al.
Publicado: (2005)

Acquired Factor X Deficiency in Light Chain Amyloidosis: A Report of 2 Korean Cases
por: Ma, Youngeun, et al.
Publicado: (2011)

Exosomal miR-1305 in the oncogenic activity of hypoxic multiple myeloma cells: a biomarker for predicting prognosis
por: Lee, Ji Young, et al.
Publicado: (2021)

The Korean Organ Transplant Registry (KOTRY): Second Official Adult Heart Transplant Report
por: Kim, Darae, et al.
Publicado: (2019)

Biomarkers in AL Amyloidosis
por: Fotiou, Despina, et al.
Publicado: (2021)

The impact of preoperative kidney replacement therapy on kidney outcome and survival in patients with left ventricular assist device
por: Jeon, Hojin, et al.
Publicado: (2023)

NCK-associated protein 1 regulates metastasis and is a novel prognostic marker for colorectal cancer
por: Kwon, Mi Ri, et al.
Publicado: (2023)

Recurrent mutations of MAPK pathway genes in multiple myeloma but not in amyloid light-chain amyloidosis
por: Kim, Seok Jin, et al.
Publicado: (2016)

Comparison of mid-term clinical outcome in heart transplantation patients using mycophenolate mofetil vs. enteric-coated mycophenolate sodium
por: Jeon, Kina, et al.
Publicado: (2022)

Impact of preoperative renal replacement therapy on the clinical outcome of heart transplant patients
por: Kim, Darae, et al.
Publicado: (2021)

Predictors and Prognostic Value of Worsening Renal Function During Admission in HFpEF Versus HFrEF: Data From the KorAHF (Korean Acute Heart Failure) Registry
por: Kang, Jeehoon, et al.
Publicado: (2018)

Clinical Outcomes of Early Extubation Strategy in Patients Undergoing Extracorporeal Membrane Oxygenation as a Bridge to Heart Transplantation
por: Youn, Taeho, et al.
Publicado: (2020)

Prognostic Value of QRS Duration among Patients with Cardiogenic Shock Complicating Acute Heart Failure: Data from the Korean Acute Heart Failure (KorAHF) Registry
por: Hong, Jung Ae, et al.
Publicado: (2020)

Prevalence of Amyloidosis in Korea
por: Seo, Su Ra, et al.
Publicado: (2017)

Favorable Impact of a Multidisciplinary Team Approach on Heart Transplantation Outcomes in a Mid-Volume Center
por: Lee, Jun Ho, et al.
Publicado: (2022)

MAGE genes: Prognostic indicators in AL amyloidosis patients
por: Liu, Yang, et al.
Publicado: (2019)

Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA
por: Suzuki, Kenshi, et al.
Publicado: (2023)

Changes in Biomarker Status in Metastatic Breast Cancer and Their Prognostic Value
por: Woo, Ji Won, et al.
Publicado: (2019)

TEAD2 as a novel prognostic factor for hepatocellular carcinoma
por: Joo, Jong Seok, et al.
Publicado: (2020)

A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
por: Jung, Hae Hyun, et al.
Publicado: (2023)

Prognostic Significance of Left Axis Deviation in Acute Heart Failure Patients with Left Bundle branch block: an Analysis from the Korean Acute Heart Failure (KorAHF) Registry
por: Choi, Ki Hong, et al.
Publicado: (2018)

Use of Extracorporeal Life Support for Heart Transplantation: Key Factors to Improve Outcome
por: Lee, Jun Ho, et al.
Publicado: (2021)

AL AMYLOIDOSIS: MECHANISMS OF DISEASE AND BIOMARKERS
por: Palladini, Giovanni, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2tc20jijatg0rmhpihu0fbj113